• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP G4 CLIP DELIVERY SYSTEM; MITRAL VALVE REPAIR DEVICES Back to Search Results
Model Number CDS0701-XTW
Device Problems Incomplete Coaptation (2507); Expulsion (2933); Physical Resistance/Sticking (4012)
Patient Problems Syncope/Fainting (4411); Embolism/Embolus (4438); Mitral Valve Insufficiency/ Regurgitation (4451); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/17/2022
Event Type  Injury  
Event Description
This is filed to report single leaflet device attachment/slda.It was reported that this was a mitraclip procedure to treat degenerative mitral regurgitation with a grade of 4.It was noted posterior prolapse and flail.The clip delivery system (cds) was advanced to the mitral valve; however when trying to grasp the posterior flail, the clip briefly interacted with chordae.The clip was ultimately able to grasp the flail and deploy the clip on both leaflets without issue.However, the brief interaction between the clip and the chordae caused some shadowing on the imaging and the anterior leaflet was difficult to see.One clip was implanted, reducing mr to 1.Then hours later, imaging showed the clip became detached from the anterior leaflet, but remained attached to the posterior leaflet (single leaflet device attachment/slda).The physician stated that the cause of the slda is unknown.Since the clip appeared stable and mr was still 1, additional treatment was not needed.The patient is stable and discharged as planned.No other information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on the available information, a cause for the single leaflet device attachment/slda) could not be determined.The reported interaction between the device and anatomy appears to be a result of procedural conditions/user technique (grasping below valve).The reported poor imaging appears to be a cascading event of the interaction between the device and anatomy.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.Based on the available information, the single leaflet device attachment (slda) appears to be due to procedural conditions.The reported interaction between the device and anatomy appears to be a result of procedural conditions/user technique (grasping below valve).A cause for the reported expulsion could not be determined.The reported poor imaging appears to be due to procedural conditions.A cause for the reported fainting could not be determined.The reported patient effects of embolism and mitral regurgitation (mr) are cascading events of the expulsion.Additionally, embolism and mr are listed in the instructions for use as known possible complications associated with mitraclip procedures.The reported hospitalization, unexpected medical interventions, and removal of foreign body were the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.
 
Event Description
Subsequent to the follow up report filed, the following additional information was received: on 5/26/2022, the patient was re-admitted and underwent a second mitraclip procedure.Two additional clips were implanted, reducing mr from 4+ to 1-2+.No other information was provided.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot-specific quality issue.A cause for the reported fainting could not be determined.It is possible that worsening patient condition contributed to this event.However, this cannot be confirmed.The reported embolism and mitral regurgitation (mr) are cascading events of the expulsion.Additionally, embolism and mr are listed in the mitraclip g4 system instructions for use (ifu) as known possible complications associated with mitraclip procedures.The reported interaction between the device and anatomy appears to be a result of procedural conditions/user technique (grasping below valve).The reported hospitalization, unexpected medical intervention, and removal of foreign body were the results of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design, or labeling.H1 - type of reportable event: updated from 'malfunction' to 'serious injury' h6 - patient codes 2199 and 4582 were removed.H10 - addtl mfg narrative: revised.
 
Event Description
This is filed to report embolized clip, prolonged hospitalization, and medical intervention.Subsequent to the final report filed, the following additional information was received: then on 3/20/2022, the patient passed out and collapsed.The patient was re-hospitalized and then it was discovered that clip came off both leaflets, embolizing to the subclavian artery and increasing mr to 4.The embolized clip was retrieved with a snare.The patient is stable and was discharged on 3/24/2022.No other information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP G4 CLIP DELIVERY SYSTEM
Type of Device
MITRAL VALVE REPAIR DEVICES
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key14074562
MDR Text Key289019924
Report Number2024168-2022-03853
Device Sequence Number1
Product Code NKM
UDI-Device Identifier08717648231001
UDI-Public08717648231001
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/17/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/25/2022
Device Model NumberCDS0701-XTW
Device Catalogue NumberCDS0701-XTW
Device Lot Number11026R166
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2022
Initial Date FDA Received04/11/2022
Supplement Dates Manufacturer Received04/26/2022
05/27/2022
Supplement Dates FDA Received05/20/2022
06/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
-
-